glp-1 receptor agonists in idiopathic intracranial hypertension The effect of agonist on hypertension: a systematic review and meta-analysis The effect of GLP-1 agonist
Description
doi: 10.1016/j.coph.2016.08.005 [DOI] [PubMed] [Google Scholar] 110
The metabolic improvements associated with GLP-1 agonist therapyincluding weight loss, improved glycaemic control, and potential benefits in MASLD (formerly known as non-alcoholic fatty liver disease)could address multiple health concerns simultaneously, though effects specifically in alcohol-related liver disease are not established
TripleHormone-Receptor agonist Retatrutide for Obesity A phase 2 trial
GLP-1RA use was significantly associated with a lower risk of all-cause mortality in this cohort compared to insulin/metformin use
